Summary
- Current Price
- As of today, REVB price is $3.94, down -4.14% on
- Current Price All-Time High
- REVB price is currently -100.00% below its historical high of $2,276,064.00 set on
- Market Cap
- REVB current market cap is $2M, up +337.57% over the past 365 days
- Revenue
- REVB current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for REVB is on
Profile
| Metric | Value |
|---|---|
| Full Name | Revelation Biosciences, Inc. |
| Ticker | NASDAQ: REVB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | revbiosciences.com |
| Employees | 8 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $3.94 | ||
| Price, 1D Change | -4.14% | |
| $2M | ||
| - | ||
| - | ||
| 0.03 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$167.62 | ||
| EPS, 1Y Change | +97.72% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:7 | |
| Next Split | N/A | N/A |
| Last Ticker Change | PAIC | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$167.62 | ||
| EPS Estimate | -$36.30 | |
| EPS Est. Change | +78.35% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| $3.94 | ||
| Price Target | $124.25 | - |
| Price Tgt. Change | +3,053.55% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$119.68 | -$7,365.39 | -6,054.24% | |
| -$36.60 | -$167.62 | -357.98% | |
| -$36.30 | N/A | +78.35% | |
| -$20.23 | N/A | +87.93% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -1.50% | ||
| -99.88% | ||
| +337.57% | ||
| +247.55% | ||
| 0.00% | ||
| 0.00% | ||
| +97.72% | ||
| +99.98% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $3.94 | ||
| $1.59 | ||
| $2.83 | ||
| $26.36 | ||
| $2.97 | ||
| $0.36 | ||
| 0.03 | ||
| $0.75 | ||
| 53.03 | ||
| 119.09% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$167.62 | ||
| -$27.10K | ||
| - | ||
| -$9.07M | ||
| - | ||
| -$8.91M | ||
| - | ||
| -$9.04M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.08 | ||
| 5.41 | ||
| 5.41 | ||
| - | ||
| - | ||
| -4.57 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 0.31 | ||
| 0.48 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $8.86M | ||
| $10.70M | ||
| $11.58M | ||
| $10.81M | ||
| $2.72M | ||
| $2.00M | ||
| $746.80K | ||
| $23.00K | ||
| $577.50K |
Expenses
| Metric | Value | Date |
|---|---|---|
| $8.91M | ||
| $9.04M | ||
| $27.10K | ||
| $5.01M | ||
| $27.10K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$8.27M | ||
| $0.00 | ||
| $12.47M | ||
| $0.00 | ||
| -$8.27M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Roth MKM | ||
| Roth Capital |
Analyst sentiment
Institutional ownership
Screeners with REVB
FAQ
- What is the ticker symbol for Revelation Biosciences, Inc.?
- The ticker symbol for Revelation Biosciences, Inc. is NASDAQ:REVB
- Does Revelation Biosciences, Inc. pay dividends?
- No, Revelation Biosciences, Inc. does not pay dividends
- What sector is Revelation Biosciences, Inc. in?
- Revelation Biosciences, Inc. is in the Healthcare sector
- What industry is Revelation Biosciences, Inc. in?
- Revelation Biosciences, Inc. is in the Biotechnology industry
- What country is Revelation Biosciences, Inc. based in?
- Revelation Biosciences, Inc. is headquartered in United States
- When did Revelation Biosciences, Inc. go public?
- Revelation Biosciences, Inc. initial public offering (IPO) was on November 17, 2020
- Is Revelation Biosciences, Inc. in the S&P 500?
- No, Revelation Biosciences, Inc. is not included in the S&P 500 index
- Is Revelation Biosciences, Inc. in the NASDAQ 100?
- No, Revelation Biosciences, Inc. is not included in the NASDAQ 100 index
- Is Revelation Biosciences, Inc. in the Dow Jones?
- No, Revelation Biosciences, Inc. is not included in the Dow Jones index
- When was Revelation Biosciences, Inc. last earnings report?
- Revelation Biosciences, Inc.'s most recent earnings report was on November 5, 2026
- When does Revelation Biosciences, Inc. report earnings?
- The next expected earnings date for Revelation Biosciences, Inc. is February 25, 2027
Data Sources & References
- REVB Official Website www.revbiosciences.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1810560/000119312526076552/0001193125-26-076552-index.htm
- REVB Profile on Yahoo Finance finance.yahoo.com/quote/REVB
- REVB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/revb
